Zenobia Fragments Alternatives & Competitors

10 companies similar to Zenobia Fragments

D&D Pharmatech

15 Grant $9.54M

Korea South

Biopharma Biotechnology +2

Anticancer Bioscience

Applying our synthetic lethality expertise for better cancer therapies

17 Seed $200.15M

Chengdu, China

Biotechnology Health Care +3

EpigenTek

Complete Solutions for Research in DNA/RNA Methylation, Histone Modifications, and Chromat...

Farmingdale, United State...

Biotechnology Health Care +1

Enable Medicine

Spatial and multimodal insights powered by AI for your next therapeutic breakthrough.

15 Acquired $63.62M

Menlo Park, United States

Biotechnology Pharmaceutical

Rival Readout

Competing with Zenobia Fragments? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Ro5

Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.

12 Seed

London, United Kingdom

AI Biotechnology +3

Celdara Medical

Transforming Innovation Into Medicine

24 Grant

Lebanon, United States

Biotechnology Health Care +1

Canntab Therapeutics

Canntab Therapeutics is the medical industry leader in solid oral dose formulations of can...

9 IPO $5.01M

Markham, Canada

Biotechnology Health Care +2

American Gene Technologies® International Inc.

Our mission is to leverage the power of gene and cell therapy to reduce human suffering fr...

26 Series F $30.20M

Rockville, United States

Biotechnology Health Care +1

DIANA Biotechnologies

DIANA Biotechnologies: Diversified Biotech

60 Seed $3.50M

Czech Republic

Biopharma Biotechnology +1

HDT Bio

Immune Therapy For All

54 Seed $17.20M

Seattle, United States

Biopharma Biotechnology +1

Frequently Asked Questions

Companies similar to Zenobia Fragments include D&D Pharmatech, Anticancer Bioscience, EpigenTek, Enable Medicine, Ro5. They work in Biotechnology and Pharmaceutical.

Bounce Watch lists 10 companies that share Zenobia Fragments's industries and are closest to it in business tags, services, target customers, business model and size.

Zenobia Therapeutics is a biotechnology and pharmaceutical company that was founded in 2008. The company recently received a significant $225.00K grant investment on 28 June 2019 from the National Science Foundation. As an emerging player in the biotech and pharmaceutical industries, Zenobia Therapeutics has been attra...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Zenobia Fragments: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Zenobia Fragments Profile D&D Pharmatech Alternatives Anticancer Bioscience Alternatives EpigenTek Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Zenobia Fragments on 15 Sep 2024. The 8 companies listed here were last checked between 11 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.